nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Boxed Warning for Montelukast: The FDA Perspective
|
Clarridge, Katherine |
|
|
9 |
7 |
p. 2638-2641 |
artikel |
2 |
A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies
|
Shaker, Marcus |
|
|
9 |
7 |
p. 2658-2668.e3 |
artikel |
3 |
African American Children Are More Likely to Be Allergic to Shellfish and Finfish: Findings from FORWARD, a Multisite Cohort Study
|
Mahdavinia, Mahboobeh |
|
|
9 |
7 |
p. 2867-2873.e1 |
artikel |
4 |
Ascertainment Bias in Anaphylaxis Safety Data of COVID-19 Vaccines
|
Hourihane, Jonathan O’B. |
|
|
9 |
7 |
p. 2562-2566 |
artikel |
5 |
A Special Thank-You to Our Fellow-in-Training and Faculty Reviewers
|
|
|
|
9 |
7 |
p. 2555 |
artikel |
6 |
Aspergillus-related diseases in a cohort of patients with severe asthma: A SANI single-center report
|
Solidoro, Paolo |
|
|
9 |
7 |
p. 2920-2922.e2 |
artikel |
7 |
Association Between Statin Medication and Asthma/Asthma Exacerbation in a National Health Screening Cohort
|
Kim, Joo-Hee |
|
|
9 |
7 |
p. 2783-2791 |
artikel |
8 |
Asthma and COVID-19
|
Singh, Pramil N. |
|
|
9 |
7 |
p. 2939 |
artikel |
9 |
Asthma Patients Who Stop Asthma Biologics Have a Similar Risk of Asthma Exacerbations as Those Who Continue Asthma Biologics
|
Jeffery, Molly M. |
|
|
9 |
7 |
p. 2742-2750.e1 |
artikel |
10 |
Chronic Respiratory Diseases and the Outcomes of COVID-19: A Nationwide Retrospective Cohort Study of 39,420 Cases
|
Guan, Wei-jie |
|
|
9 |
7 |
p. 2645-2655.e14 |
artikel |
11 |
Chronic Rhinosinusitis of Odontogenic Origin
|
Clark, James H. |
|
|
9 |
7 |
p. 2894-2895 |
artikel |
12 |
Clinical disparity of primary antibody deficiency patients at a safety net hospital
|
Wallace, Luke J. |
|
|
9 |
7 |
p. 2923-2925.e1 |
artikel |
13 |
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity
|
Milito, Cinzia |
|
|
9 |
7 |
p. 2904-2906.e2 |
artikel |
14 |
Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma Registry
|
Denton, Eve |
|
|
9 |
7 |
p. 2680-2688.e7 |
artikel |
15 |
CME Exam: Management Strategies to Reduce Exacerbations in non-T2 Asthma
|
|
|
|
9 |
7 |
p. 2598 |
artikel |
16 |
CME Exam: Prevention and Outpatient Treatment of Asthma Exacerbations in Children
|
|
|
|
9 |
7 |
p. 2577 |
artikel |
17 |
CME Exam: Prevention and Treatment of Asthma Exacerbations in Adults
|
|
|
|
9 |
7 |
p. 2587 |
artikel |
18 |
Complications of switching from anti–IL-5 or anti–IL-5R to dupilumab in corticosteroid-dependent severe asthma
|
Eger, Katrien |
|
|
9 |
7 |
p. 2913-2915 |
artikel |
19 |
Concerns about the approach of measuring allergens in early introduction foods for prevention of food allergy
|
Weihe, Olivia |
|
|
9 |
7 |
p. 2944-2945 |
artikel |
20 |
Continuing Medical Education Calendar
|
|
|
|
9 |
7 |
p. A35-A36 |
artikel |
21 |
Cover 1
|
|
|
|
9 |
7 |
p. OFC |
artikel |
22 |
COVID-19 in a series of patients with aspirin-exacerbated respiratory disease
|
White, Andrew A. |
|
|
9 |
7 |
p. 2900-2903 |
artikel |
23 |
COVID-19 “infodemics” and asthmatic children: The return to school challenge
|
Boechat, José Laerte |
|
|
9 |
7 |
p. 2940 |
artikel |
24 |
Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score
|
Pérez de Llano, Luis |
|
|
9 |
7 |
p. 2725-2731 |
artikel |
25 |
Editorial Board
|
|
|
|
9 |
7 |
p. A31 |
artikel |
26 |
Effect of COVID-19 on asthma exacerbation
|
Salciccioli, Justin D. |
|
|
9 |
7 |
p. 2896-2899.e1 |
artikel |
27 |
Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Rα in a real-world setting
|
Bavaro, Nicole |
|
|
9 |
7 |
p. 2910-2912.e1 |
artikel |
28 |
Exacerbation-Prone Asthma: A Biological Phenotype or a Social Construct
|
Federico, Monica J. |
|
|
9 |
7 |
p. 2627-2634 |
artikel |
29 |
Factors Associated with Frequent Exacerbations in the UK Severe Asthma Registry
|
Yang, Freda |
|
|
9 |
7 |
p. 2691-2701.e1 |
artikel |
30 |
Fruit-Induced Anaphylaxis: Clinical Presentation and Management
|
Gabrielli, Sofianne |
|
|
9 |
7 |
p. 2825-2830.e2 |
artikel |
31 |
Hormone Replacement Therapy and Risk of Severe Asthma Exacerbation in Perimenopausal and Postmenopausal Women: 17-Year National Cohort Study
|
Nwaru, Bright I. |
|
|
9 |
7 |
p. 2751-2760.e1 |
artikel |
32 |
Immune Dysregulation in Human ITCH Deficiency Successfully Treated with Hematopoietic Cell Transplantation
|
Patel, Trusha |
|
|
9 |
7 |
p. 2885-2893.e3 |
artikel |
33 |
Impact of Rapid Transition to Telemedicine-Based Delivery on Allergy/Immunology Care During COVID-19
|
Tsao, Lulu R. |
|
|
9 |
7 |
p. 2672-2679.e2 |
artikel |
34 |
Inflammatory T2 Biomarkers in Severe Asthma Patients: The First Step to Precision Medicine
|
Bossios, Apostolos |
|
|
9 |
7 |
p. 2689-2690 |
artikel |
35 |
Information for Readers
|
|
|
|
9 |
7 |
p. A32 |
artikel |
36 |
International multicenter experience of transjugular intrahepatic portosystemic shunt implantation in patients with common variable immunodeficiency
|
Globig, Anna-Maria |
|
|
9 |
7 |
p. 2931-2935.e1 |
artikel |
37 |
Management of Asthma Exacerbations in the Emergency Department
|
Hasegawa, Kohei |
|
|
9 |
7 |
p. 2599-2610 |
artikel |
38 |
Management Strategies to Reduce Exacerbations in non-T2 Asthma
|
Murphy, Ryan C. |
|
|
9 |
7 |
p. 2588-2597 |
artikel |
39 |
Mechanics and Economics of a Negative Pressure Pulmonary Function Lab in the COVID-19 Era
|
Olsen, Timothy C. |
|
|
9 |
7 |
p. 2936-2938 |
artikel |
40 |
Mechanisms and Treatment of the Diverse Presentations of Acute Wheezing and Asthma
|
Gern, James E. |
|
|
9 |
7 |
p. 2635-2637 |
artikel |
41 |
Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry
|
Thomas, Dennis |
|
|
9 |
7 |
p. 2715-2724.e5 |
artikel |
42 |
Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?
|
Akdime, Florie |
|
|
9 |
7 |
p. 2942-2943 |
artikel |
43 |
Mepolizumab-responsive Kimura disease
|
Kinoshita, Manao |
|
|
9 |
7 |
p. 2928-2930 |
artikel |
44 |
More Data on Risks and Outcomes of COVID-19 in Asthma, COPD, and Bronchiectasis
|
Chung, Kian Fan |
|
|
9 |
7 |
p. 2656-2657 |
artikel |
45 |
Moving FORWARD Toward Racial Equity in Food Allergy
|
Davis, Carla M. |
|
|
9 |
7 |
p. 2874-2875 |
artikel |
46 |
Novel Treatment-Refractory Preschool Wheeze Phenotypes Identified by Cluster Analysis of Lung Lavage Constituents
|
Teague, W. Gerald |
|
|
9 |
7 |
p. 2792-2801.e4 |
artikel |
47 |
Original Article Highlights From This Issue
|
|
|
|
9 |
7 |
p. A21-A27 |
artikel |
48 |
Patient-Selected Treatment Goals in Severe Asthma
|
Mulvey, Christopher |
|
|
9 |
7 |
p. 2732-2741.e1 |
artikel |
49 |
Performance of Eosinophil Cationic Protein as a Biomarker in Asthmatic Children
|
Shah, Sheel N. |
|
|
9 |
7 |
p. 2761-2769.e2 |
artikel |
50 |
Practice Notes from the AAAI
|
|
|
|
9 |
7 |
p. A33-A34 |
artikel |
51 |
Predicting Severe Asthma Exacerbations in Children: Blueprint for Today and Tomorrow
|
Navanandan, Nidhya |
|
|
9 |
7 |
p. 2619-2626 |
artikel |
52 |
Predictors of Asthma Control and Exacerbations: A Real-World Study
|
Racine, Geneviève |
|
|
9 |
7 |
p. 2802-2811.e2 |
artikel |
53 |
Prevalence and Trend of Allergen Sensitization in Adults and Children with Atopic Dermatitis Referred for Patch Testing, North American Contact Dermatitis Group Data, 2001-2016
|
Silverberg, Jonathan I. |
|
|
9 |
7 |
p. 2853-2866.e14 |
artikel |
54 |
Prevention and Outpatient Treatment of Asthma Exacerbations in Children
|
Murray, Clare S. |
|
|
9 |
7 |
p. 2567-2576 |
artikel |
55 |
Prevention and Treatment of Asthma Exacerbations in Adults
|
Menzies-Gow, Andrew |
|
|
9 |
7 |
p. 2578-2586 |
artikel |
56 |
Racial, Ethnic, and Socioeconomic Disparities in the Diagnosis and Management of Primary Immunodeficiencies
|
Breidenbaugh, Marc |
|
|
9 |
7 |
p. 2926-2927 |
artikel |
57 |
Real-life small airway outcomes in severe asthma patients receiving biologic therapies
|
Chan, Rory |
|
|
9 |
7 |
p. 2907-2909 |
artikel |
58 |
Real-World Effectiveness of Omalizumab in Severe Allergic Asthma: A Meta-Analysis of Observational Studies
|
Bousquet, Jean |
|
|
9 |
7 |
p. 2702-2714 |
artikel |
59 |
Reply to “Concerns about the approach of measuring allergens in early introduction foods for prevention of food allergy”
|
Filep, Stephanie |
|
|
9 |
7 |
p. 2945-2946 |
artikel |
60 |
Reply to “Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?”
|
Caminati, Marco |
|
|
9 |
7 |
p. 2943-2944 |
artikel |
61 |
Table of Contents
|
|
|
|
9 |
7 |
p. A6, A8, A10, A12, A14, A16-A20 |
artikel |
62 |
The association of plasma IL-6 with measures of asthma morbidity in a moderate-severe pediatric cohort aged 6-18 years
|
Permaul, Perdita |
|
|
9 |
7 |
p. 2916-2919.e2 |
artikel |
63 |
The Cost-Effectiveness of Preschool Peanut Oral Immunotherapy in the Real-World Setting
|
Shaker, Marcus |
|
|
9 |
7 |
p. 2876-2884.e4 |
artikel |
64 |
The hidden allergen: Triton X-100, a derivative of polyethylene glycol
|
Herman, Sari M. |
|
|
9 |
7 |
p. 2941 |
artikel |
65 |
The impact of inhaled corticosteroid on SARS-CoV2 infection
|
Lai, Chih-Cheng |
|
|
9 |
7 |
p. 2939-2940 |
artikel |
66 |
The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis
|
Shaker, Marcus |
|
|
9 |
7 |
p. 2556-2561 |
artikel |
67 |
The Importance of Binomial Nomenclature for the Identification of Pollen Aeroallergens
|
Ramon, German Dario |
|
|
9 |
7 |
p. 2642-2644 |
artikel |
68 |
Total IgE Variability Is Associated with Future Asthma Exacerbations: A 1-Year Prospective Cohort Study
|
Yuan, Yu Lai |
|
|
9 |
7 |
p. 2812-2824 |
artikel |
69 |
Treatable Traits in Elderly Asthmatics from the Australasian Severe Asthma Network: A Prospective Cohort Study
|
Wu, Wen Wen |
|
|
9 |
7 |
p. 2770-2782 |
artikel |
70 |
Trends in Emergency Department Visits and Hospitalizations for Acute Allergic Reactions and Anaphylaxis Among US Older Adults: 2006-2014
|
Arroyo, Anna Chen |
|
|
9 |
7 |
p. 2831-2843.e8 |
artikel |
71 |
What a Dime Can Buy You
|
Lang, David M. |
|
|
9 |
7 |
p. 2669-2671 |
artikel |
72 |
Wheat Anaphylaxis in Adults Differs from Reactions to Other Types of Food
|
Kraft, Magdalena |
|
|
9 |
7 |
p. 2844-2852.e5 |
artikel |
73 |
Which Wheezing Preschoolers Should be Treated for Asthma?
|
Bacharier, Leonard B. |
|
|
9 |
7 |
p. 2611-2618 |
artikel |